Variations requiring assessment (veterinary medicines)
Submitted by Anonymous (not verified) on 3 July 2026 - 9:54
Variations requiring assessment (veterinary medicines)
Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop on regulatory sandbox, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 21 September 2026, 13:30 (CEST) to 21 September 2026, 17:00 (
Submitted by Anonymous (not verified) on 3 July 2026 - 9:46
Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop on regulatory sandbox, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 21 September 2026, 13:30 (CEST) to 21 September 2026, 17:00 (CEST)
Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib citrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000226763
Submitted by Anonymous (not verified) on 3 July 2026 - 9:40
Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, tofacitinib citrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: EMA/PE/0000226763
Meeting of the HMA-EMA group focused on AI with industry stakeholders - June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, 2 June 2026
Submitted by Anonymous (not verified) on 3 July 2026 - 9:33
Meeting of the HMA-EMA group focused on AI with industry stakeholders - June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, 2 June 2026
EMA/PE/0000236669
Submitted by Anonymous (not verified) on 3 July 2026 - 9:30
EMA/PE/0000236669
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Submitted by Anonymous (not verified) on 3 July 2026 - 9:28
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Date of authorisation: 06/06/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 3 July 2026 - 9:23
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Date of authorisation: 06/06/2025, Revision: 2, Status: Authorised
EMA/PE/0000238977
Submitted by Anonymous (not verified) on 3 July 2026 - 9:21
EMA/PE/0000238977
EMEA-003002-PIP04-23
Submitted by Anonymous (not verified) on 3 July 2026 - 9:13
EMEA-003002-PIP04-23
Combination Products Operational Group: agendas and highlight reports
Submitted by Anonymous (not verified) on 3 July 2026 - 9:12
Combination Products Operational Group: agendas and highlight reports